摘要:
The present invention provides a solid form and compositions thereof, which are useful as metal chelators and which exhibit desirable characteristics for the same.
摘要:
Desferrithiocin analogues represented by the structural formulae described here, such as formula (I), are useful in treating conditions such as metal overload ( e.g. , iron overload from transfusion therapy), oxidative stress, and neoplastic and preneoplastic conditions.
摘要:
The present invention is directed to novel thiazoline derivatives of the general fomula (I); wherein all variables are as herein defined, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
摘要:
Phenyl- and pyridyl-substituted thiazoline acid derivatives useful in diagnosing and treating pathological conditions associated with an excess of trivalent metals in humans and animals.
摘要:
Verfahren zur Herstellung von substituierten Thiazolinen der Formel (1) in der Ar einen Phenyl-, Naphthyl-, Thienyl-, Pyridyl- oder Chinolinylrest bedeuten, der gegebenenfalls durch ein oder mehrere Substituenten aus der Gruppe Halogen, OH, Benzyloxy, C 1 -C 4 -Alkyl, C 1 -C 4 -Alkoxy, COOR 1 mit R 1 gleich H oder C 1 -C 4 -Alkyl substituiert sein kann, durch Kopplung von (S)-α-Methylcystein-Hydrochlorid der Formel (II) mit einem Nitril der Formel (III)
Ar-CN
in der Ar wie oben definiert ist, oder einem korrespondierenden C 1 -C 4 -Alkylimidat, bei welchem (S)-α-Methylcystein-Hydrochlorid der Formel (II) in einem geeigneten Lösungsmittel mit an einem Nitril der Formel (III) oder einem korrespondierenden C 1 -C 4 -Alkylimidat in Gegenwart einer tertiären Base bei einem pH-Wert von 6.5 bis 10 bei 50°C bis zur Rückflusstemperatur zu dem entsprechenden Thiazolin der Formel (I) umgesetzt wird, sowie Verfahren zur Herstellung von (S)-α-Methylcystein-Hydrochlorid und dessen Verwendung zur Herstellung von Thiazolinen der Formel (I).
摘要:
A compound represented by general formula (I) and useful for treating or preventing mycoplasmal infection, wherein M represents a di- or trivalent metal ion; and X represents OH or Oo.
摘要:
[Problem] It is an object of the present invention to provide a firefly luciferin and firefly luciferin analog that are modified to maintain luminescent activity by luciferase in a firefly bioluminescent system. In particular, it is an object of the present invention to provide a new luminescent substrate for which the emission wavelength in a firefly bioluminescent system is shifted to a longer wavelength than that of a conventional luminescent substrate. [Solution] The present invention provides a luciferin in which the benzothiazole ring moiety has been modified at the 7-position, a luciferin analog in which the benzene ring moiety has been modified at the 6-position, and a luciferin analog in which the 6-(dialkylamino)-2-naphthalenyl moiety has been modified at the 5-position.
摘要:
Composition, article of manufacture for and method of treating malaria in a human having an infestation of Plasmodium protozoans are described. The method comprises administering a therapeutically effective amount of a compound of formula (I) or (IV), i.e., sufficient quantity to reduce the population of Plasmodium. The composition of the invention is a compound of formula (I) or (IV) with a pharmaceutical excipient. The article of manufacture is the composition in combination with labelling for treating malaria. The substituents are detailed in the specification.
摘要:
Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.